Insider Selling: The Cooper Companies, Inc. (NASDAQ:COO) CFO Sells 24,788 Shares of Stock

The Cooper Companies, Inc. (NASDAQ:COO) CFO Brian G. Andrews sold 24,788 shares of Cooper Companies stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $105.90, for a total value of $2,625,049.20. Following the sale, the chief financial officer now directly owns 6,614 shares of the company’s stock, valued at approximately $700,422.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Cooper Companies Stock Performance

NASDAQ COO opened at $106.59 on Monday. The company has a 50-day simple moving average of $93.30 and a two-hundred day simple moving average of $94.62. The Cooper Companies, Inc. has a 12-month low of $75.93 and a 12-month high of $107.82. The firm has a market cap of $21.22 billion, a price-to-earnings ratio of 62.70, a PEG ratio of 2.56 and a beta of 0.98. The company has a quick ratio of 1.14, a current ratio of 1.99 and a debt-to-equity ratio of 0.33.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The company had revenue of $1 billion during the quarter, compared to analysts’ expectations of $997.30 million. During the same period in the prior year, the business posted $0.84 EPS. Cooper Companies’s quarterly revenue was up 7.8% compared to the same quarter last year. On average, equities analysts forecast that The Cooper Companies, Inc. will post 3.66 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Piper Sandler lifted their price target on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $115.00 target price (up from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Jefferies Financial Group raised shares of Cooper Companies from a “hold” rating to a “buy” rating and boosted their price target for the stock from $107.00 to $115.00 in a research note on Tuesday, July 16th. Robert W. Baird raised their price objective on shares of Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research report on Thursday, August 29th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $113.61.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in COO. Benjamin F. Edwards & Company Inc. raised its holdings in Cooper Companies by 248.6% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 244 shares of the medical device company’s stock valued at $25,000 after buying an additional 174 shares during the last quarter. Brown Brothers Harriman & Co. increased its position in shares of Cooper Companies by 412.2% in the fourth quarter. Brown Brothers Harriman & Co. now owns 251 shares of the medical device company’s stock valued at $95,000 after acquiring an additional 202 shares during the period. Covestor Ltd raised its stake in shares of Cooper Companies by 305.9% during the first quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock valued at $28,000 after acquiring an additional 208 shares during the last quarter. Innealta Capital LLC bought a new position in shares of Cooper Companies during the second quarter valued at about $25,000. Finally, Global Retirement Partners LLC boosted its holdings in shares of Cooper Companies by 358.6% during the first quarter. Global Retirement Partners LLC now owns 321 shares of the medical device company’s stock worth $33,000 after purchasing an additional 251 shares during the period. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.